Cost Effectiveness

Orthopedic surgery is a marvelous field because we can make meaningful improvements in the comfort and function of patients disabled by arthritis, instability, tendon tears, developmental disorders and fractures.

Cost-effectiveness and optimal stopping ages for colorectal cancer screening after age 75 years appear to be associated with an individual’s age, sex, comorbidity status and screening history, according to results of an economic evaluation.

A daily polypill was estimated to be cost-effective for primary CVD prevention among U.S. adults living in historically underserved communities with limited health care access and low income, researchers reported.

Inpatient total knee arthroplasty for patients with a high comorbidity burden may not be cost-effective, as published results showed increased procedural costs were not met with increased hospital revenue in this patient population.

Researchers estimate that semaglutide 2.4 mg is not cost-effective for secondary CVD prevention for patients with overweight or obesity without diabetes, according to an Australian study.

For patients with COPD who experienced an exacerbation in the last 12 months, add-on azithromycin therapy was deemed cost-effective, according to results published in Annals of the American Thoracic Society.

During a Midwest Comparative Effectiveness Public Advisory Council public meeting, 11 of 15 members believed current evidence was adequate in showing the net health benefit of ensifentrine plus maintenance therapy.

When added to maintenance therapy for moderate to severe COPD, ensifentrine improves lung function and exacerbation rate vs. placebo, according to a draft evidence report by the Institute for Clinical and Economic Review.

The cost-effectiveness of routine COVID-19 testing among nursing home staff depended on the virulence of variants circulating during the time of testing, researchers found.

Researchers found lisocabtagene maraleucel to be a cost-effective second-line treatment option for patients with relapsed or refractory diffuse large B-cell lymphoma, study findings published in Blood Advances showed.